Can-Fite BioPharma Ltd. (NYSEMKT:CANF)

CAPS Rating: 1 out of 5

CANF News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

4 Outperform
24 Underperform
 

All-Star Players

0 Outperform
15 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top CANF Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

jed71 (99.84)
Submitted May 05, 2015

Greatest hits from the December 2014 prospectus .... "Our net tangible book value as of September 30, 2014 was $2,982,000, or $0.34 per ADS. After giving effect to the sale of the ADSs in the aggregate amount of approximately $8,000,000 at an… More

CANF VS S&P 500 (SPY)

CANF Summary

Recent Community Commentary

Read the most recent pitches from players about CANF.

Recs

0
Member Avatar pchop12316 (92.68) Submitted: 5/9/2017 10:20:52 AM : Underperform Start Price: $1.78 CANF Score: +0.69

likely to keep falling in value

Recs

0
Member Avatar carsondyle (79.68) Submitted: 11/29/2015 9:39:25 AM : Outperform Start Price: $3.36 CANF Score: -63.64

Five institutions have taken new positions recently, I thinks shorts have over stayed and will get burned, I think they may have something here now with the cancer and NASH applications. Fast track in the US, orphan drug in Europe, already approved for compassionate use.

Recs

3
Member Avatar jed71 (99.84) Submitted: 5/5/2015 12:01:23 PM : Underperform Start Price: $2.43 CANF Score: +42.89

Greatest hits from the December 2014 prospectus ....

"Our net tangible book value as of September 30, 2014 was $2,982,000, or $0.34 per ADS. After giving effect to the sale of the ADSs in the aggregate amount of approximately $8,000,000 at an offering price of $4.45 per ADS, and after deducting estimated offering commissions and expenses payable by us, our net tangible book value as of September 30, 2014 would have been $8,165,000, or $0.77 per ordinary share. This represents an immediate increase in the net tangible book value of $0.43 per ADS to our existing shareholders and an immediate and substantial dilution in net tangible book value of $3.68 per ADS to new investors."

"We effected a 1-for-25 reverse share split with respect to our ordinary shares, options and warrants on May 12, 2013. Reported prices in the table below have been adjusted to give retroactive effect to the share split."

My favorite....

"Since we have broad discretion in how we use the proceeds from this offering, we may use the proceeds in ways with which you disagree. We have not allocated specific amounts of the net proceeds from this offering for any specific purpose. Accordingly, our management will have significant flexibility in applying the net proceeds of this offering. You will be relying on the judgment of our management with regard to the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used in ways with which you would agree. It is possible that the net proceeds will be invested in a way that does not yield a favorable, or any, return for us. The failure of our management to use such funds effectively could have a material adverse effect on our business, financial condition, operating results and cash flow."

Leaderboard

Find the members with the highest scoring picks in CANF.

Score Leader

TSIF

TSIF (99.97) Score: +145.21

The Score Leader is the player with the highest score across all their picks in CANF.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
PestAssassin0065 45.00 12/29/2015 Underperform 5Y $3.05 -40.33% +19.13% +59.46 0 Comment
losingtoday 96.80 4/4/2016 Underperform 1Y $2.87 -36.59% +19.84% +56.42 0 Comment
patatepoil6 99.91 4/20/2016 Underperform 5Y $2.92 -37.67% +17.69% +55.37 0 Comment
Gvozden 99.90 5/26/2016 Underperform 5Y $2.79 -34.77% +17.94% +52.70 0 Comment
Zencyclone 29.87 4/27/2015 Underperform 5Y $2.74 -33.46% +16.41% +49.86 0 Comment
jasonrivera < 20 1/13/2016 Underperform 5Y $2.25 -19.11% +30.27% +49.38 0 Comment
CreamPlay 67.09 3/22/2016 Underperform 5Y $2.49 -26.91% +20.77% +47.68 0 Comment
bonznstonz < 20 3/17/2016 Underperform 5Y $2.45 -25.71% +21.58% +47.29 0 Comment
jed71 99.84 5/5/2015 Underperform 5Y $2.43 -25.10% +17.78% +42.89 3 Comments
XMFYoung 99.97 5/13/2015 Underperform 1Y $2.41 -24.48% +17.48% +41.95 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CANF.

Featured Broker Partners